@article{944bfa05dcf1451daa8cb28e2d6152f5,
title = "From tissue to human regeneration: The development of a comprehensive regenerative care clinic for people with diabetes",
keywords = "clinic, diabetes, innovation, practice, regenerative",
author = "Hargraves, {Ian G.} and Atta Behfar and Vinaya Simha and Chenoa Donoghue and Renner, {Amy Seegmiller} and Montori, {Victor M.} and Brito, {Juan P.}",
note = "Funding Information: The development of the comprehensive regenerative care clinic for people with diabetes is supported by the Center of Regenerative Medicine at Mayo Clinic. A Behfar has the following disclosures: Rion LLC, Co-Founder and Board of Directors Sorento Therapeutics, Stock holder Deverra Therapeutics, Share holder Chenoa Donoghue discloses: Stockholder for Metronic, Pfizer and Merck.",
year = "2021",
month = mar,
doi = "10.2217/rme-2020-0176",
language = "English (US)",
volume = "16",
pages = "225--228",
journal = "Regenerative Medicine",
issn = "1746-0751",
publisher = "Future Medicine Ltd.",
number = "3",
}